Oncology Small Molecule Drugs Market Size, Trends, Growth & Outlook

Oncology Small Molecule Drugs Market - By Drug Class (Chemotherapy Drugs, Immunomodulating Drugs, Targeted Therapy Drugs, Hormonal Therapy), By Indication (Non-small Cell Lung Cancer, Renal Cell Carcinoma, Breast Cancer, Prostate Cancer, Melanoma, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics, Online Pharmacies) & Global Region - Market Size, Trends, Opportunity, Forecast 2019 - 2027

Industry: Life Science | Report ID: FAMI-00601 | Published on: Nov, 2019 | View: 1707 | Share:         

Request Sample Enquire Before Buying Request Discount

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

  • Report Descripton
  • Table Of Content
  • Request Methodology
  • Request Customization

Facto Market Insights added a title on “Oncology Small Molecule Drugs Market – 2019 - 2027” to its collection of industry research reports. The Oncology Small Molecule Drugs Market research report represents the analysis of all the segments, which includes the market size, Y-O-Y growth analysis and structure of the overall industry based on a unique combination of industry research, fieldwork, market sizing analysis, and our in-house expertise.

The Oncology Small Molecule Drugs Market research report demonstrates market dynamics, which includes growth drivers, barriers, opportunities, and trends spearheading current nature and future status of this market. Facto Market Insights’ study also consists of the recent developments that are setting the level of competition in the Oncology Small Molecule Drugs Market, along with accurate and complete information about the major & niche players in the market.

Moreover, Porter’s Five Forces analysis demonstrates the five forces which include buyers bargaining power, suppliers bargaining power, the threat of new entrants, the threat of substitutes, and degree of competition in the Global Oncology Small Molecule Drugs Market. Along with figures and tables, market attractiveness and BPS analysis have been provided for every segment in the report. In addition to this, the report offers recent industry activities and value chain analysis for the Oncology Small Molecule Drugs Market.

Global Oncology Small Molecule Drugs Market Segmentation          

The research offers a comprehensive analysis of global Oncology Small Molecule Drugs Market with respect to following sub-markets:

Oncology Small Molecule Drugs Market, by Drug Class:

  • Chemotherapy Drugs
    • Alkylating Agents
    • Antimetabolites
    • Other Drugs
  • Immunomodulating Drugs
  • Hormonal Therapy
  • Targeted Therapy Drugs
    • Proteasome Inhibitors
    • Tyrosine Kinase Inhibitors
    • mTOR Inhibitors
    • Others

Oncology Small Molecule Drugs Market, by Indication Type:

  • Breast Cancer
  • Prostate Cancer
  • Multiple Myeloma
  • Melanoma
  • Lymphoma
  • Leukemia
  • Non-small Cell Lung Cancer (NSCLC)
  • Renal Cell Carcinoma
  • Others

Oncology Small Molecule Drugs Market, by Route of Administration:

  • Oral
  • Injectable

Oncology Small Molecule Drugs Market, by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Specialty Clinics
  • Online Pharmacies

Oncology Small Molecule Drugs Market, By Region:

The report analyses the market by geographies i.e. North America, Europe, Asia Pacific, Latin America & Middle East & Africa. Further, the geographies are fragmented into the country and regional groupings:

- North America (U.S. & Canada)

- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)

- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)

- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)

- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Global Oncology Small Molecule Drugs Market: Competitive Landscape

The report also highlights the competitive landscape of the global Oncology Small Molecule Drugs Market, market share and positioning of all the major players in the industry. The competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as company overview, financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, technology development, research & development and other market activities).

The report includes profiles of leading companies in the global Oncology Small Molecule Drugs Market. Some of the key players profiled include:

  • Pfizer Inc
  • F. Hoffman
  • Sanofi S.A
  • AbbVie Inc
  • Incyte Corporation
  • AstraZeneca plc
  • Millennium Pharmaceuticals
  • Novartis AG
  • Amgen Inc
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • Bayer AG
  • Celgene Corporation
  • Exelixis Inc

Get a sample pages of this report Click here

Research Methodology

Market Definition and List of Abbreviations

1.    Executive Summary
2.    Growth Drivers & Issues in Global Oncology Small Molecule Drugs Market
3.    Global Oncology Small Molecule Drugs Market Trends
4.    Opportunities in Global Oncology Small Molecule Drugs Market
5.    Recent Industry Activities, 2017
6.    Porter's Five Forces Analysis
7.    Market Value Chain and Supply Chain Analysis
8.    Global Oncology Small Molecule Drugs Market Size (USD Million), Growth Analysis and Forecast, (2019 - 2027)

9.    Global Oncology Small Molecule Drugs Market Segmentation Analysis, By Drug Class

9.1.    Introduction
9.2.    Market Attractiveness, By Drug Class
9.3.    BPS Analysis, By Drug Class
9.4.    Chemotherapy Drugs
9.4.1.    Alkylating Agents 
9.4.2.    Antimetabolites
9.4.3.    Other Drugs
9.5.    Immunomodulating Drugs
9.6.    Hormonal Therapy
9.7.    Targeted Therapy Drugs
9.7.1.    Proteasome Inhibitors 
9.7.2.    Tyrosine Kinase Inhibitors
9.7.3.    mTOR Inhibitors 
9.7.4.    Others

10.     Global Oncology Small Molecule Drugs Market Segmentation Analysis, By Indication Type

10.1.    Introduction
10.2.    Market Attractiveness, By Indication Type
10.3.    BPS Analysis, By Indication Type
10.4.    Breast Cancer
10.5.    Prostate Cancer
10.6.    Multiple Myeloma
10.7.    Melanoma
10.8.    Lymphoma
10.9.    Leukemia
10.10.    Non-small Cell Lung Cancer (NSCLC)
10.11.    Renal Cell Carcinoma
10.12.    Others

11.    Global Oncology Small Molecule Drugs Market Segmentation Analysis, By Route of Administration

11.1.    Introduction
11.2.    Market Attractiveness, By Route of Administration
11.3.    BPS Analysis, By Route of Administration
11.4.    Oral
11.5.    Injectable

12.    Global Oncology Small Molecule Drugs Market Segmentation Analysis, By Distribution Channel

12.1.    Introduction
12.2.    Market Attractiveness, By Distribution Channel
12.3.    BPS Analysis, By Distribution Channel
12.4.    Hospital Pharmacies
12.5.    Retail Pharmacies
12.6.    Specialty Clinics
12.7.    Online Pharmacies

13.    Geographical Analysis

13.1.    Introduction
13.2.    North America Oncology Small Molecule Drugs Market Size (USD Million), 2019 - 2027
13.2.1.    By Drug Class
13.2.2.    By Indication Type
13.2.3.    By Route of Administration
13.2.4.    By Distribution Channel
13.2.5.    By Country
13.2.5.1.    Market Attractiveness, By End-user
13.2.5.2.    BPS Analysis, By End-User
13.2.5.3.    U.S. Market Size (USD Million), 2019 - 2027
13.2.5.4.    Canada Market Size (USD Million), 2019 - 2027

13.3.    Europe Oncology Small Molecule Drugs Market Size (USD Million), 2019 - 2027

13.3.1.    By Drug Class
13.3.2.    By Indication Type
13.3.3.    By Route of Administration
13.3.4.    By Distribution Channel
13.3.5.    By Country
13.3.5.1.    Market Attractiveness, By Country
13.3.5.2.    BPS Analysis, By Country
13.3.5.3.    Germany Market Size (USD Million), 2019 - 2027
13.3.5.4.    United Kingdom Market Size (USD Million), 2019 - 2027
13.3.5.5.    France Market Size (USD Million), 2019 - 2027
13.3.5.6.    Italy Market Size (USD Million), 2019 - 2027
13.3.5.7.    Spain Market Size (USD Million), 2019 - 2027
13.3.5.8.    Russia Market Size (USD Million), 2019 - 2027
13.3.5.9.    Rest of Europe Market Size (USD Million), 2019 - 2027

13.4.    Asia Pacific Oncology Small Molecule Drugs Market Size (USD Million), 2019 - 2027

13.4.1.    By Drug Class
13.4.2.    By Indication Type
13.4.3.    By Route of Administration
13.4.4.    By Distribution Channel
13.4.5.    By Country
13.4.5.1.    Market Attractiveness, By Country
13.4.5.2.    BPS Analysis, By Country
13.4.5.3.    China Market Size (USD Million), 2019 - 2027
13.4.5.4.    India Market Size (USD Million), 2019 - 2027
13.4.5.5.    Japan Market Size (USD Million), 2019 - 2027
13.4.5.6.    South Korea Market Size (USD Million), 2019 - 2027
13.4.5.7.    Indonesia Market Size (USD Million), 2019 - 2027
13.4.5.8.    Taiwan Market Size (USD Million), 2019 - 2027
13.4.5.9.    Australia Market Size (USD Million), 2019 - 2027
13.4.5.10.    New Zealand Market Size (USD Million), 2019 - 2027
13.4.5.11.    Rest of Asia Pacific Market Size (USD Million), 2019 - 2027

13.5.    Latin America Oncology Small Molecule Drugs Market Size (USD Million), 2019 - 2027

13.5.1.    By Drug Class
13.5.2.    By Indication Type
13.5.3.    By Route of Administration
13.5.4.    By Distribution Channel
13.5.5.    By Country
13.5.5.1.    Market Attractiveness, By Country
13.5.5.2.    BPS Analysis, By Country
13.5.5.3.    Brazil Market Size (USD Million), 2019 - 2027
13.5.5.4.    Mexico Market Size (USD Million), 2019 - 2027
13.5.5.5.    Rest of Latin America Market Size (USD Million), 2019 - 2027

13.6.    Middle East & Africa Oncology Small Molecule Drugs Market Size (USD Million), 2019 - 2027

13.6.1.    By Drug Class
13.6.2.    By Indication Type
13.6.3.    By Route of Administration
13.6.4.    By Distribution Channel
13.6.5.    By Country
13.6.5.1.    Market Attractiveness, By Geography
13.6.5.2.    BPS Analysis, By Geography
13.6.5.3.    GCC Market Size (USD Million), 2019 - 2027
13.6.5.4.    North Africa Market Size (USD Million), 2019 - 2027
13.6.5.5.    South Africa Market Size (USD Million), 2019 - 2027
13.6.5.6.    Rest of Middle East & Africa Market Size (USD Million), 2019 – 2029

14.     Competitive Landscape

14.1.    Pfizer Inc
14.2.    F. Hoffman
14.3.    Sanofi S.A
14.4.    AbbVie Inc
14.5.    Incyte Corporation
14.6.    AstraZeneca plc
14.7.    Millennium Pharmaceuticals
14.8.    Novartis AG
14.9.    Amgen Inc
14.10.    Eli Lilly and Company
14.11.    Bristol-Myers Squibb Company
14.12.    Bayer AG
14.13.    Celgene Corporation
14.14.    Exelixis Inc
 

Select License Type
  • Single User License $3840 USD
  • Multi-User License $5370 USD
  • Corporate User License $6450 USD

Our Clients

  • +1 518-300-1215Mon-Fri, 24Hrs
  • [email protected]We reply within an hours
  • Albany,
    NY, USA.